Arden Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $551K | Sell |
13,257
-4,121
| -24% | -$184K | 0.08% | 130 |
|
|
2024
Q1 | $942K | Sell |
17,378
-203
| -1% | -$10.3K | 0.13% | 109 |
|
|
2023
Q4 | $902K | Sell |
17,581
-658
| -4% | -$34.5K | 0.13% | 110 |
|
|
2023
Q3 | $1.06M | Sell |
18,239
-377
| -2% | -$23.1K | 0.18% | 84 |
|
|
2023
Q2 | $1.19M | Sell |
18,616
-136
| -0.7% | -$9.12K | 0.2% | 84 |
|
|
2023
Q1 | $1.3M | Sell |
18,752
-91
| -0.5% | -$6.42K | 0.23% | 91 |
|
|
2022
Q4 | $1.36M | Sell |
18,843
-80
| -0.4% | -$6.03K | 0.28% | 80 |
|
|
2022
Q3 | $1.34M | Sell |
18,923
-1,550
| -8% | -$112K | 0.34% | 70 |
|
|
2022
Q2 | $1.58M | Sell |
20,473
-1,837
| -8% | -$140K | 0.36% | 70 |
|
|
2022
Q1 | $1.63M | Sell |
22,310
-1,050
| -4% | -$70.5K | 0.32% | 68 |
|
|
2021
Q4 | $1.46M | Sell |
23,360
-1,550
| -6% | -$90.9K | 0.25% | 87 |
|
|
2021
Q3 | $1.47M | Sell |
24,910
-3,050
| -11% | -$201K | 0.25% | 88 |
|
|
2021
Q2 | $1.87M | Sell |
27,960
-647
| -2% | -$42.2K | 0.31% | 69 |
|
|
2021
Q1 | $1.81M | Sell |
28,607
-1,821
| -6% | -$113K | 0.3% | 66 |
|
|
2020
Q4 | $1.89M | Sell |
30,428
-6,204
| -17% | -$381K | 0.31% | 62 |
|
|
2020
Q3 | $2.21M | Sell |
36,632
-1,935
| -5% | -$116K | 0.4% | 46 |
|
|
2020
Q2 | $2.27M | Sell |
38,567
-414
| -1% | -$24.8K | 0.42% | 48 |
|
|
2020
Q1 | $2.17M | Sell |
38,981
-770
| -2% | -$47.1K | 0.43% | 38 |
|
|
2019
Q4 | $2.55M | Sell |
39,751
-1,902
| -5% | -$109K | 0.4% | 51 |
|
|
2019
Q3 | $2.11M | Sell |
41,653
-254
| -0.6% | -$11.9K | 0.34% | 59 |
|
|
2019
Q2 | $1.9M | Sell |
41,907
-1,615
| -4% | -$75.2K | 0.32% | 65 |
|
|
2019
Q1 | $2.08M | Sell |
43,522
-1,220
| -3% | -$60.8K | 0.33% | 56 |
|
|
2018
Q4 | $2.33M | Sell |
44,742
-3,632
| -8% | -$195K | 0.42% | 47 |
|
|
2018
Q3 | $3M | Sell |
48,374
-5,819
| -11% | -$345K | 0.47% | 37 |
|
|
2018
Q2 | $3M | Sell |
54,193
-1,073
| -2% | -$58K | 0.48% | 37 |
|
|
2018
Q1 | $3.5M | Sell |
55,266
-300
| -0.5% | -$19.3K | 0.54% | 33 |
|
|
2017
Q4 | $3.4M | Sell |
55,566
-4,066
| -7% | -$254K | 0.52% | 36 |
|
|
2017
Q3 | $3.8M | Sell |
59,632
-899
| -1% | -$52.5K | 0.58% | 31 |
|
|
2017
Q2 | $3.37M | Sell |
60,531
-2,372
| -4% | -$129K | 0.52% | 34 |
|
|
2017
Q1 | $3.42M | Buy |
62,903
+264
| +0.4% | +$14.5K | 0.53% | 38 |
|
|
2016
Q4 | $3.66M | Sell |
62,639
-9,553
| -13% | -$522K | 0.56% | 35 |
|
|
2016
Q3 | $3.89M | Sell |
72,192
-52,339
| -42% | -$3.36M | 0.6% | 36 |
|
|
2016
Q2 | $9.16K | Buy |
124,531
+683
| +0.6% | +$48.3K | 0.69% | 37 |
|
|
2016
Q1 | $7.91M | Buy |
123,848
+1,220
| +1% | +$76.9K | 0.63% | 45 |
|
|
2015
Q4 | $8.44M | Buy |
122,628
+304
| +0.2% | +$20.1K | 0.71% | 35 |
|
|
2015
Q3 | $7.24M | Buy |
122,324
+29,460
| +32% | +$1.87M | 0.6% | 41 |
|
|
2015
Q2 | $6.18K | Sell |
92,864
-2,232
| -2% | -$147K | 0.92% | 21 |
|
|
2015
Q1 | $6.13K | Buy |
95,096
+16,564
| +21% | +$1.04M | 0.89% | 23 |
|
|
2014
Q4 | $4.64M | Sell |
78,532
-2,971
| -4% | -$168K | 0.64% | 30 |
|
|
2014
Q3 | $4.17M | Buy |
81,503
+3,842
| +5% | +$192K | 0.57% | 33 |
|
|
2014
Q2 | $3.77M | Sell |
77,661
-1,131
| -1% | -$55.7K | 0.51% | 37 |
|
|
2014
Q1 | $4.09M | Buy |
78,792
+9,266
| +13% | +$493K | 0.5% | 36 |
|
|
2013
Q4 | $3.7M | Buy |
69,526
+1,936
| +3% | +$98.6K | 0.45% | 42 |
|
|
2013
Q3 | $3.13M | Buy |
67,590
+9,973
| +17% | +$438K | 0.4% | 40 |
|
|
2013
Q2 | $2.58M | Buy |
+57,617
| New | +$2.5M | 0.31% | 59 |
|
Other funds holding BMY
Arden Trust's BMY Position: Q2 2024 in Review
Arden Trust reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q2 2024, selling an estimated $184K and leaving 13,257 shares worth $551K. The position accounts for 0.08% of the portfolio, ranked #130.
Arden Trust first reported a position in BMY in Q2 2013 and has held it in 45 quarters since. The position peaked at $8.44M in Q4 2015. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Arden Trust held 13,257 shares of Bristol-Myers Squibb worth $551K as of Q2 2024.
- Arden Trust sold 4,121 Bristol-Myers Squibb shares in Q2 2024, an estimated $184K.
- Bristol-Myers Squibb made up 0.08% of Arden Trust's portfolio in Q2 2024, its #130 holding.
- Arden Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Bristol-Myers Squibb position peaked at $8.44M in Q4 2015.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.